170491-62-0 Usage
General Description
1-Pyrrolidinecarboxylic acid, 2-(2-oxoethyl)-, 1,1-dimethylethyl ester is a chemical compound with the molecular formula C13H23NO3. It is a derivative of pyrrolidinecarboxylic acid, a cyclic amino acid commonly found in various biological systems. The 2-(2-oxoethyl) group and the 1,1-dimethylethyl ester side chain give this compound unique properties, making it useful in pharmaceutical and chemical research. Its precise applications are not well documented in the literature, but it may have potential as a building block in organic synthesis or as a precursor to novel pharmaceutical compounds. As with all chemicals, proper handling and safety precautions should be observed when working with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 170491-62-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,4,9 and 1 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 170491-62:
(8*1)+(7*7)+(6*0)+(5*4)+(4*9)+(3*1)+(2*6)+(1*2)=130
130 % 10 = 0
So 170491-62-0 is a valid CAS Registry Number.
170491-62-0Relevant articles and documents
NOVEL HISTONE METHYLTRANSFERASE INHIBITORS
-
, (2021/04/01)
The present invention relates to novel compounds of formula (I) as defined herein. The compounds are inhibitors of histone methyltransferases of the seven-beta-strand family, in particular of KMT9.
USE OF AMINOINDANE COMPOUNDS IN TREATING OVERACTIVE BLADDER AND INTERSTITIAL CYSTITIS
-
, (2014/03/22)
The present application provides methods of using the aminoindane compounds of formula (I) or (II) in treating an overactive bladder or interstitial cystitis by administering one or more of the compounds to a patient.
ANTIBACTERIAL FLUOROQUINOLONE ANALOGS
-
Page/Page column 42, (2011/04/18)
Compounds having antibacterial activity are disclosed. The compounds have one of the following structures (I) or (II): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein A, B, J, D, E, G, W, R1, R2/su